NIH consensus development conference statement: Lactose intolerance and health
- PMID: 20186234
NIH consensus development conference statement: Lactose intolerance and health
Abstract
Objective: To provide health care providers, patients, and the general public with a responsible assessment of currently available data on lactose intolerance and health.
Participants: A non-DHHS, nonadvocate 14-member panel representing the fields of internal medicine, pediatrics, pediatric and adult endocrinology, gastroenterology, hepatology, neonatology and perinatology, geriatrics, racial/ethnic disparities, radiology, maternal and fetal nutrition, vitamin and mineral metabolism, nutritional sciences, bone health, preventive medicine, biopsychology, biostatistics, statistical genetics, epidemiology, and a public representative. In addition, 22 experts from pertinent fields presented data to the panel and conference audience.
Evidence: Presentations by experts and a systematic review of the literature prepared by the University of Minnesota Evidence-based Practice Center, through the Agency for Healthcare Research and Quality. Scientific evidence was given precedence over anecdotal experience.
Conference process: The panel drafted its statement based on scientific evidence presented in open forum and on published scientific literature. The draft statement was presented on the final day of the conference and circulated to the audience for comment. The panel released a revised statement later that day at http://consensus.nih.gov. This statement is an independent report of the panel and is not a policy statement of the NIH or the Federal Government.
Conclusions: • Lactose intolerance is a real and important clinical syndrome, but its true prevalence is not known. • The majority of people with lactose malabsorption do not have clinical lactose intolerance. Many individuals who think they are lactose intolerant are not lactose malabsorbers. • Many individuals with real or perceived lactose intolerance avoid dairy and ingest inadequate amounts of calcium and vitamin D, which may predispose them to decreased bone accrual, osteoporosis, and other adverse health outcomes. In most cases, individuals do not need to eliminate dairy consumption completely. • Evidence-based dietary approaches with and without dairy foods and supplementation strategies are needed to ensure appropriate consumption of calcium and other nutrients in lactose-intolerant individuals. • Educational programs and behavioral approaches for individuals and their healthcare providers should be developed and validated to improve the nutrition and symptoms of individuals with lactose intolerance and dairy avoidance.
Similar articles
-
NIH consensus development conference draft statement on vaginal birth after cesarean: new insights.NIH Consens State Sci Statements. 2010 Mar 10;27(3):1-42. NIH Consens State Sci Statements. 2010. PMID: 20228855
-
NIH Consensus Statement on Management of Hepatitis C: 2002.NIH Consens State Sci Statements. 2002 Jun 10-12;19(3):1-46. NIH Consens State Sci Statements. 2002. PMID: 14768714
-
NIH State-of-the-Science Conference Statement on management of menopause-related symptoms.NIH Consens State Sci Statements. 2005 Mar 21-23;22(1):1-38. NIH Consens State Sci Statements. 2005. PMID: 17308548
-
Diagnosis and management of dental caries throughout life.NIH Consens Statement. 2001 Mar 26-28;18(1):1-23. NIH Consens Statement. 2001. PMID: 11699634
-
NIH state-of-the-science conference statement: Preventing Alzheimer's disease and cognitive decline.NIH Consens State Sci Statements. 2010 Apr 28;27(4):1-30. NIH Consens State Sci Statements. 2010. PMID: 20445638
Cited by
-
Dairy nutrition educational messages help increase dairy product knowledge, purchasing, and consumption.JDS Commun. 2023 Oct 6;5(1):13-17. doi: 10.3168/jdsc.2023-0417. eCollection 2024 Jan. JDS Commun. 2023. PMID: 38223383 Free PMC article.
-
Whey permeate powder is a suitable ingredient for ice cream.JDS Commun. 2023 Sep 18;4(6):439-442. doi: 10.3168/jdsc.2023-0382. eCollection 2023 Nov. JDS Commun. 2023. PMID: 38045891 Free PMC article.
-
Improving lactose digestion and symptoms of lactose intolerance with a novel galacto-oligosaccharide (RP-G28): a randomized, double-blind clinical trial.Nutr J. 2013 Dec 13;12:160. doi: 10.1186/1475-2891-12-160. Nutr J. 2013. PMID: 24330605 Free PMC article. Clinical Trial.
-
Validity of a Portable Breath Analyser (AIRE) for the Assessment of Lactose Malabsorption.Nutrients. 2019 Jul 17;11(7):1636. doi: 10.3390/nu11071636. Nutrients. 2019. PMID: 31319625 Free PMC article.
-
Estimating Lactase Nonpersistence Distributions in the Multi-Ethnic Canadian Demographic: A Population-Based Study.J Can Assoc Gastroenterol. 2020 Jun;3(3):103-110. doi: 10.1093/jcag/gwy068. Epub 2018 Nov 28. J Can Assoc Gastroenterol. 2020. PMID: 32395684 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical